MEDIORGPharmaceuticals
MEDICAMEN ORGANICS — Balance Sheet
₹21.20
+2.42%
MEDICAMEN ORGANICS Balance Sheet (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Ordinary Shares Number | 1.17 Cr | 1.17 Cr | 1.17 Cr | 1.17 Cr |
| Share Issued | 1.17 Cr | 1.17 Cr | 1.17 Cr | 1.17 Cr |
| Net Debt | 12.10 Cr | 11.27 Cr | 9.81 Cr | 8.71 Cr |
| Total Debt | 12.66 Cr | 11.79 Cr | 10.25 Cr | 9.59 Cr |
| Tangible Book Value | 15.17 Cr | 8.97 Cr | 8.00 Cr | 7.45 Cr |
| Invested Capital | 27.84 Cr | 20.77 Cr | 18.26 Cr | 17.06 Cr |
| Working Capital | 5.48 Cr | -1.03 Cr | -2.11 Cr | -2.34 Cr |
| Net Tangible Assets | 15.17 Cr | 8.97 Cr | 8.00 Cr | 7.45 Cr |
| Common Stock Equity | 15.18 Cr | 8.98 Cr | 8.01 Cr | 7.47 Cr |
| Total Capitalization | 15.35 Cr | 9.31 Cr | 8.65 Cr | 8.11 Cr |
| Total Equity Gross Minority Interest | 15.18 Cr | 8.98 Cr | 8.01 Cr | 7.47 Cr |
| Stockholders Equity | 15.18 Cr | 8.98 Cr | 8.01 Cr | 7.47 Cr |
| Retained Earnings | 4.47 Cr | 2.07 Cr | 1.10 Cr | 0.55 Cr |
| Additional Paid In Capital | 2.11 Cr | 0.91 Cr | 0.91 Cr | 0.91 Cr |
| Capital Stock | 8.60 Cr | 6.00 Cr | 6.00 Cr | 6.00 Cr |
| Common Stock | 8.60 Cr | 6.00 Cr | 6.00 Cr | 6.00 Cr |
| Total Liabilities Net Minority Interest | 23.40 Cr | 23.61 Cr | 19.53 Cr | 18.88 Cr |
| Total Non Current Liabilities Net Minority Interest | 1.56 Cr | 1.71 Cr | 1.99 Cr | 1.81 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | 0.21 Cr | 0.22 Cr | 0.23 Cr | 0.20 Cr |
| Non Current Deferred Taxes Liabilities | 1.19 Cr | 1.16 Cr | 1.11 Cr | 0.98 Cr |
| Long Term Debt And Capital Lease Obligation | 0.16 Cr | 0.33 Cr | 0.64 Cr | 0.64 Cr |
| Long Term Debt | 0.16 Cr | 0.33 Cr | 0.64 Cr | 0.64 Cr |
| Current Liabilities | 21.84 Cr | 21.90 Cr | 17.54 Cr | 17.07 Cr |
| Current Debt And Capital Lease Obligation | 12.50 Cr | 11.47 Cr | 9.60 Cr | 8.95 Cr |
| Current Debt | 12.50 Cr | 11.47 Cr | 9.60 Cr | 8.95 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | 0.33 Cr | 0.27 Cr | 0.20 Cr | 0.20 Cr |
| Current Provisions | 1.17 Cr | 0.44 Cr | 0.15 Cr | 0.16 Cr |
| Payables | 7.51 Cr | 9.28 Cr | 7.51 Cr | 7.44 Cr |
| Other Payable | 0.22 Cr | 0.14 Cr | 0.14 Cr | 0.33 Cr |
| Total Tax Payable | 0.20 Cr | 0.14 Cr | 0.06 Cr | 0.09 Cr |
| Accounts Payable | 7.08 Cr | 9.00 Cr | 7.31 Cr | 7.02 Cr |
| Total Assets | 38.58 Cr | 32.59 Cr | 27.54 Cr | 26.34 Cr |
| Total Non Current Assets | 11.27 Cr | 11.72 Cr | 12.11 Cr | 11.62 Cr |
| Non Current Prepaid Assets | 0.23 Cr | 0.28 Cr | 0.24 Cr | 0.16 Cr |
| Goodwill And Other Intangible Assets | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.02 Cr |
| Other Intangible Assets | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.02 Cr |
| Net PPE | 10.49 Cr | 10.86 Cr | 11.28 Cr | 11.34 Cr |
| Accumulated Depreciation | -6.53 Cr | -5.81 Cr | -5.10 Cr | -4.42 Cr |
| Gross PPE | 17.01 Cr | 16.66 Cr | 16.38 Cr | 15.76 Cr |
| Construction In Progress | 0.15 Cr | 0.00 | 0.00 | 0.00 |
| Other Properties | 1.64 Cr | 1.56 Cr | 1.51 Cr | 1.51 Cr |
| Machinery Furniture Equipment | 9.90 Cr | 9.78 Cr | 9.55 Cr | 8.93 Cr |
| Buildings And Improvements | 5.33 Cr | 5.33 Cr | 5.32 Cr | 5.32 Cr |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets | 27.31 Cr | 20.87 Cr | 15.43 Cr | 14.72 Cr |
| Prepaid Assets | 3.92 Cr | 3.43 Cr | 4.02 Cr | 3.65 Cr |
| Inventory | 6.14 Cr | 6.14 Cr | 4.72 Cr | 2.66 Cr |
| Finished Goods | 1.31 Cr | 0.12 Cr | 0.36 Cr | 0.07 Cr |
| Work In Process | 1.78 Cr | 1.51 Cr | 0.66 Cr | 0.24 Cr |
| Raw Materials | 3.05 Cr | 4.52 Cr | 3.70 Cr | 2.35 Cr |
| Accounts Receivable | 16.70 Cr | 10.77 Cr | 6.25 Cr | 7.53 Cr |
| Cash Cash Equivalents And Short Term Investments | 0.55 Cr | 0.53 Cr | 0.44 Cr | 0.88 Cr |
| Cash And Cash Equivalents | 0.55 Cr | 0.53 Cr | 0.44 Cr | 0.88 Cr |
| Cash Equivalents | 0.12 Cr | 0.09 Cr | 0.07 Cr | 0.14 Cr |
| Cash Financial | 0.43 Cr | 0.44 Cr | 0.37 Cr | 0.74 Cr |
| Other Non Current Liabilities | — | 31000.00 | — | — |
| Non Current Deferred Taxes Assets | — | 0.00 | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on MEDICAMEN ORGANICS
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.